Upstream Bio, Inc.
UPB
$8.95
-$0.16-1.76%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -128.39% | -128.90% | -157.91% | -176.57% | -205.82% |
| Total Depreciation and Amortization | 111.24% | 233.33% | 159.65% | 103.42% | 48.33% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 461.66% | 654.77% | 192.11% | 146.35% | 112.72% |
| Change in Net Operating Assets | -68.55% | -912.66% | -1,206.99% | -42.07% | 143.51% |
| Cash from Operations | -125.23% | -119.61% | -144.97% | -76.16% | -56.02% |
| Capital Expenditure | 67.71% | 9.20% | -- | -609.72% | -254.86% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -58.23% | -3.68% | -63.61% | -1,092.85% | 28.69% |
| Cash from Investing | -57.15% | -3.64% | -64.20% | -1,091.41% | 28.19% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -99.12% | 2,814.34% | 2,781.65% | 2,772.47% | 239,016.10% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -99.95% | -99.95% | 131.45% | 15.73% |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 99.14% | -23.37% | -2,811.28% | -- | -- |
| Cash from Financing | -99.42% | 83.61% | 79.94% | 452.46% | 223.36% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -174.71% | 376.64% | -122.46% | 1,204.71% | 3,318.96% |